Hoffmann-La Roche Can't Shake $1.4B Tamiflu FCA Suit
Hoffmann-La Roche Inc. can't escape a False Claims Act suit alleging that it fraudulently induced the federal government to spend $1.4 billion on stockpiling Tamiflu to thwart an influenza outbreak, a...To view the full article, register now.
Already a subscriber? Click here to view full article